Show your work
How we know what we know
Every condition, every diet, every major ingredient flag — with the research, guidelines, and practitioner work behind it.
Every condition and every major ingredient flag in Velrae Method is informed by published research, clinical guidelines, or named practitioner consensus. Where evidence is contested, we say so. Where it’s folk wisdom that predates the evidence, we say that too.
This page is the source you can hand your doctor. Nothing on this page is medical advice. Always work with your physician, dietitian, or specialist.
Conditions
Hashimoto’s thyroiditis — Krysiak R et al. (Exp Clin Endocrinol Diabetes, 2019); Endocrine Society clinical practice guidelines; Izabella Wentz, PharmD, Hashimoto’s Protocol.
Lupus (SLE) — EULAR 2023 recommendations; Roberts & Hayashi (NEJM 1983, alfalfa case report).
Crohn’s / Ulcerative Colitis / IBD — Chassaing B et al. (Nature 2015, emulsifiers); Tobacman JK (Environ Health Perspect 2001, carrageenan); ACG Clinical Guidelines (Crohn’s 2018, UC 2019).
IBS — Monash University FODMAP Program; Halmos EP et al. (Gastroenterology 2014).
Celiac disease — ACG Clinical Guideline 2023; NIH Celiac Disease Awareness Campaign.
Type 1 & 2 diabetes — ADA Standards of Care 2024; DiRECT trial (Lean et al., Lancet 2018).
Perimenopause — NAMS 2022 Position Statement; Mary Claire Haver MD The New Menopause; Stacy Sims PhD Roar and Next Level; Cochrane reviews on phytoestrogens and vasomotor symptoms.
Hypertension & DASH — AHA/ACC 2017 Hypertension Guidelines (2023 update); Appel LJ et al. (NEJM 1997); Sacks FM et al. (NEJM 2001, DASH-Sodium); NHLBI DASH eating plan.
Diet protocols
Mediterranean diet — PREDIMED (Estruch R et al., NEJM 2018); Lyon Diet Heart Study (de Lorgeril et al., Circulation 1999); UC Davis Olive Center on EVOO authenticity.
MIND diet — Morris MC et al., Alzheimers Dement 2015.
GLP-1 weight management — Apovian CM et al. (Obesity Pillars 2024, body composition); Bauer J et al. (J Am Med Dir Assoc 2013, protein); Wharton S et al. (Diabetes Obes Metab 2022, GI tolerability); Spencer Nadolsky DO practitioner guidance.
Autoimmune Protocol (AIP) — Wahls TL et al. (J Altern Complement Med 2014, foundational); practitioner-consensus reintroduction protocols. Note: large-trial evidence is limited; we cite the practitioner consensus alongside the limitation.
Major ingredient flags
Carrageenan — Tobacman 2001; Borthakur A et al. (Am J Physiol Gastrointest Liver Physiol 2007). Flagged for IBD; not flagged for general population.
Endocrine disruptors — Endocrine Society Scientific Statement (Gore AC et al., Endocr Rev 2015); EWG Skin Deep database.
How we work
- Where guidelines disagree, we follow the more conservative one.
- Where practitioner consensus runs ahead of RCT evidence, we cite both and flag the limitation.
- Where folk wisdom predates evidence, we flag as user-reported triggers.
- We don’t cite Wikipedia or general health blogs as primary sources.
If you find a source we missed, an error we made, or a study you believe changes the picture — email velraemethod@gmail.com. We update.
